Our data demonstrated that TS irreversibly crosslinks PRX3 through its active site Cys residues to form inactive covalent dimers, leading to increased mROS levels, reduced FOXM1 expression and anti-tumor activity in both in vitro and in vivo malignant mesothelioma (MM) tumor models. Here, FOXM1 is linked to neoplasm.